G. Charles Robb

2012

In 2012, G. Charles Robb earned a total compensation of $386.3K as Chief Financial Officer and Secretary at Corcept Therapeutics, a 74% decrease compared to previous year.

Compensation breakdown

Bonus$77,250
Salary$309,000
Total$386,250

Robb received $309K in salary, accounting for 80% of the total pay in 2012.

Robb also received $77.3K in bonus.

Rankings

In 2012, G. Charles Robb's compensation ranked 9,489th out of 11,487 executives tracked by ExecPay. In other words, Robb earned more than 17.4% of executives.

ClassificationRankingPercentile
All
9,489
out of 11,487
17th
Division
Manufacturing
3,512
out of 4,253
17th
Major group
Chemicals And Allied Products
964
out of 1,198
20th
Industry group
Drugs
723
out of 920
21st
Industry
Pharmaceutical Preparations
561
out of 700
20th
Source: SEC filing on April 20, 2015.

Robb's colleagues

We found four more compensation records of executives who worked with G. Charles Robb at Corcept Therapeutics in 2012.

2012

Joseph Belanoff

Corcept Therapeutics

Chief Executive Officer

2012

Steven Lo

Corcept Therapeutics

Senior Vice President, Oncology

2012

Robert Roe

Corcept Therapeutics

Secretary

2012

Anne LeDoux

Corcept Therapeutics

Chief Accounting Officer

News

You may also like